EPS: As of FY2025 Q1, the actual value is USD -0.13.<h3>Segment Revenue</h3><ul><li>Interest Earned on Investments Held in Trust Account: $78,407 for the three months ended March 31, 2025, compared to $541,076 for the same period in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Operating and Formation Costs: $411,373 for the three months ended March 31, 2025, compared to $461,331 for the same period in 2024.</li><li>Net Loss: $405,712 for the three months ended March 31, 2025, compared to net income of $32,539 for the same period in 2024.</li><li>Loss from Operations: - $416,642 for the three months ended March 31, 2025, compared to - $497,691 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $123,717 for the three months ended March 31, 2025, compared to - $94,092 for the same period in 2024.</li><li>Net Cash Used in Investing Activities: - $60,471 for the three months ended March 31, 2025, compared to - $76,923 for the same period in 2024.</li><li>Net Cash Provided by Financing Activities: $169,965 for the three months ended March 31, 2025, compared to $75,688 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Chinese Income Taxes Payable: $514,765 as of March 31, 2025, compared to $447,288 as of December 31, 2024.</li><li>Chinese VAT and Surcharges Payable: $332,208 as of March 31, 2025, compared to $326,939 as of December 31, 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to consummate a business combination before the mandatory liquidation date of November 18, 2025, as extended by the 2024 Extension Amendment.</li><li>Non-Core Business: The company has issued promissory notes to the sponsor to extend the time available to complete a business combination, with outstanding borrowings of $480,000 as of March 31, 2025.</li></ul>

DISTOKEN ACQUISITION CORP C/WTS 30/11/2027 (TO PUR ORD) | 10-Q: FY2025 Q1 EPS: USD -0.13